ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001

Researchers Plan to Extend Phase IIa Asonep Trial

August 29, 2014

In Brief: Senate Committee Finishes Work On Renewal Bill, Both Houses (So Far) Leave NCI Authorities Intact

May 21, 1982

2006 demonstration project to pay $23 per office visit.

November 4, 2005

Finasteride For Prostate Cancer Prevention Causes Little Or No Sexual Dysfunction

August 31, 2007